Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Innate Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IPHA.
You can purchase shares of Innate Pharma (NASDAQ:IPHA) through any online brokerage.
Other companies in Innate Pharma’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Voyager Therapeutics (NASDAQ:VYGR), Tango Therapeutics (NASDAQ:TNGX) and Sangamo Therapeutics (NASDAQ:SGMO).
Innate Pharma has a consensus price target of $10.83.
The stock price for Innate Pharma (NASDAQ: IPHA) is $1.98 last updated April 14, 2025 at 3:29 PM EDT.
There are no upcoming dividends for Innate Pharma.
Innate Pharma’s FY earnings are confirmed for Thursday, March 27, 2025.
There is no upcoming split for Innate Pharma.
Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.